Detection of human T-lymphotropic virus type-I DNA and mRNA in the lymph nodes; using polymerase chain reaction in situ hybridization (PCR/ISH) and reverse transcription (RT-PCR/ISH)

Int J Cancer. 1996 Mar 28;66(1):18-23. doi: 10.1002/(SICI)1097-0215(19960328)66:1<18::AID-IJC4>3.0.CO;2-1.

Abstract

To examine the relationship between human T-lymphotrophic virus type I (HTLV-I) proviral DNA and its expression in the lymph nodes, HTLV-I DNA and tax/rex mRDA were directly amplified by polymerase chain reaction in situ hybridization (PCR/ISH), and reverse transcription (RT)-PCR/ISH [RT-PCR/ISH]. We studied 24 lymph nodes from patients with adult T-cell leukemia/lymphoma (ATLL), incipient ATLL (I-ATLL), and HTLV-I associated lymphadenitis dermatopathic type (HAL-D) and enlarged paracortical type (HAL-EP). In ATLL, 40-60% of the nucleated cells were positive for for HTLV-I proviral DNA by PCR/ISH, while in I-ATLL and HAL, respectively 5-20% and less than 1-5% of cells were positive. The number of mRNA expressing cells was smaller than that of the proviral DNA-positive cells. The mRNA-expressing cells varied in number among the ATLL and I-ATLL cases, while they were only rarely observed in HAL-D and HAL-EP. These results show that HTLV-I infection and activation might increase with malignant transformation of the target T helper cells.

MeSH terms

  • Adult
  • Aged
  • DNA, Viral / analysis*
  • Female
  • Gene Expression Regulation, Neoplastic
  • Gene Expression Regulation, Viral
  • HTLV-I Infections / diagnosis*
  • HTLV-I Infections / genetics
  • Human T-lymphotropic virus 1 / genetics*
  • Humans
  • In Situ Hybridization / methods*
  • Leukemia, T-Cell / microbiology*
  • Lymph Nodes / microbiology*
  • Male
  • Middle Aged
  • Polymerase Chain Reaction / methods*
  • RNA, Viral / analysis*

Substances

  • DNA, Viral
  • RNA, Viral